Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Patients × Dexmedetomidine × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Pain, Postoperative 3 Sleep Initiation and Maintenance Disorders 1 Pain 1 Female Patients Under the Age of 65 Who Will Undergo Breast Cancer Surgery 1 Chronic Pain 1 Breast Cancer Patients 1 Breast Cancer Female 1

Interventions

Polymorphism, Single Nucleotide 2 Neoadjuvant Therapy 2 Amplified Fragment Length Polymorphism Analysis 2 elacestrant 1 Surgical Procedures, Operative 1 Dexmedetomidine 1 DEAE-Dextran 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03046238 2017-02-27

Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Breast Cancer Patients

South Egypt Cancer Institute

Phase 3 Unknown

Breast Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡